ALLY KAPUTA: Open Payments
NPI 1548942907 · GREENSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,371 in 126 payments from 19 companies in 2025. Trend: 2023 $56 · 2024 $1,266 · 2025 $2,371
Food & beverage: $2,353Speaker / faculty: $18
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $709 |
| Eisai Inc. | 16 | $330 |
| ACADIA Pharmaceuticals Inc | 7 | $225 |
| Vanda Pharmaceuticals Inc. | 5 | $220 |
| MDD US Operations, LLC | 16 | $210 |
| PFIZER INC. | 12 | $168 |
| Neurocrine BioSciences, Inc. | 9 | $151 |
| Lilly USA, LLC | 3 | $70 |
| Novartis Pharmaceuticals Corporation | 3 | $62 |
| SK Life Science, Inc. | 1 | $34 |
Products named: QULIPTA, Leqembi, UBRELVY, NUPLAZID, PONVORY, INGREZZA, NURTEC ODT, Gocovri.
Industry payments across PA — which companies pay providers there.
